MULTIPLE SCLEROSIS RELAPSE

This adverse event was reported 45881 times

These drugs are most commonly taken by patients reporting MULTIPLE SCLEROSIS RELAPSE:

# Drug Count
0 NATALIZUMAB 14037
1 INTERFERON BETA-1A 10282
2 DIMETHYL FUMARATE 5155
3 FINGOLIMOD HCL 5122
4 DALFAMPRIDINE 3510
5 BACLOFEN 2369
6 ERGOCALCIFEROL 2317
7 TERIFLUNOMIDE 2157
8 GABAPENTIN 2156
9 INTERFERON BETA-1B 1626
See all common drugs associated with MULTIPLE SCLEROSIS RELAPSE

MULTIPLE SCLEROSIS RELAPSE is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 REPOSITORY CORTICOTROPIN 51 0.0990
1 SIPONIMOD 31 0.0975
2 METOPROLOL SUCCINATE AND HYDROCHLOROTHIAZIDE 3 0.0909
3 NATALIZUMAB 14037 0.0908
4 TERIFLUNOMIDE 2157 0.0905
5 FINGOLIMOD HCL 5122 0.0823
6 INTERFERON BETA-1B 1626 0.0795
7 INTERFERON BETA-1A 10282 0.0772
8 PEGINTERFERON BETA-1A 584 0.0708
9 DALFAMPRIDINE 3510 0.0608
See all drugs enriched for association with MULTIPLE SCLEROSIS RELAPSE

MULTIPLE SCLEROSIS RELAPSE is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Stimulant Laxative [EPC] 59 0.0063
1 Tetracycline-class Drug [EPC] 52 0.0018
2 Nonsteroidal Anti-inflammatory Drug [EPC] 18 0.0012
3 Angiotensin Converting Enzyme Inhibitor [EPC] 88 0.0011
4 Antiarrhythmic [EPC] 4 0.0005
5 Insulin Analog [EPC] 47 0.0005
See all drug classes enriched for association with MULTIPLE SCLEROSIS RELAPSE